A new trading day began on Monday, with Unicycive Therapeutics Inc (NASDAQ: UNCY) stock price down -6.53% from the previous day of trading, before settling in for the closing price of $4.75. UNCY’s price has ranged from $3.71 to $11.00 over the past 52 weeks.
Healthcare Sector giant saw their annual sales slid by -31.80% over the last five years. Meanwhile, its annual earnings per share averaged 72.77%. With a float of $15.24 million, this company’s outstanding shares have now reached $17.66 million.
Unicycive Therapeutics Inc (UNCY) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Unicycive Therapeutics Inc is 13.73%, while institutional ownership is 37.47%.
Unicycive Therapeutics Inc (UNCY) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.5 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.6 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 72.77% per share during the next fiscal year.
Unicycive Therapeutics Inc (NASDAQ: UNCY) Trading Performance Indicators
Here are Unicycive Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach 9.77 in one year’s time.
Technical Analysis of Unicycive Therapeutics Inc (UNCY)
Analysing the last 5-days average volume posted by the [Unicycive Therapeutics Inc, UNCY], we can find that recorded value of 0.89 million was better than the volume posted last year of 0.39 million. As of the previous 9 days, the stock’s Stochastic %D was 14.69%.
During the past 100 days, Unicycive Therapeutics Inc’s (UNCY) raw stochastic average was set at 16.09%, which indicates a significant increase from 3.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.34 in the past 14 days, which was lower than the 0.38 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.43, while its 200-day Moving Average is $5.35. Now, the first resistance to watch is $4.67. This is followed by the second major resistance level at $4.89. The third major resistance level sits at $5.02. If the price goes on to break the first support level at $4.31, it is likely to go to the next support level at $4.18. Should the price break the second support level, the third support level stands at $3.96.
Unicycive Therapeutics Inc (NASDAQ: UNCY) Key Stats
With a market capitalization of 78.42 million, the company has a total of 17,662K Shares Outstanding. Currently, annual sales are 0 K while annual income is -36,730 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,450 K.
